131 days ago by Amigos da Associaçao

EXTON, Pa., 30/09/2011 /PRNewswire/ - ViroPharma Incorporated (NASDAQ: VPHM) anunciou hoje a licença dos direitos mundiais da Intellect Neurosciences, Inc. (OTCBB: ILNS), para a estágio clínico do OX1, um medicamento que está a ser desenvolvido para o tratamento da Ataxia de Friedreich (AF), uma doe ...

Artigos Ataxias ... - artigosataxiashereditarias.blogspot.com · 1 reference

134 days ago by Ryan McBride

ViroPharma is banking on an anti-oxidant compound to combat a rare neurological disease. The Exton, PA-based company ( $VPHM) grabbed a worldwide license to the compound from Intellect Neurosciences and plans to continue its development against Friedreich's Ataxia. Intellect Neurosciences, a tiny de ...

FierceBiotech - fiercebiotech.com/news/frontpage · Rank: 53,955 · 72 references